{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:09:51Z","timestamp":1777648191138,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100015581","name":"Houston Methodist Research Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015581","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Nylands nation Finland (J.W.)"},{"name":"Victoriastiftelsen Finland (J.W.)"},{"name":"Cancer Center Support Grant MD Anderson Cancer Center (E.V.)"},{"name":"Houston Methodist Startup Fund (H.S.)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.colsurfb.2015.10.005","type":"journal-article","created":{"date-parts":[[2015,10,17]],"date-time":"2015-10-17T05:31:00Z","timestamp":1445059860000},"page":"694-703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Multistage vector delivery of sulindac and silymarin for prevention of colon cancer"],"prefix":"10.1016","volume":"136","author":[{"given":"Maria Principia","family":"Scavo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy","family":"Wolfram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Barone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5300-4289","authenticated-orcid":false,"given":"Michael","family":"Evangelopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan O.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuewu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Celia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ennio","family":"Tasciotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Vilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifa","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2015.10.005_bib0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1897-4287-11-15","article-title":"Familial adenomatous polyposis of the colon","volume":"11","author":"Plawski","year":"2013","journal-title":"Hered. Cancer Clin. Pract."},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0010","doi-asserted-by":"crossref","first-page":"e96023","DOI":"10.1371\/journal.pone.0096023","article-title":"Rapamycin inhibition of polyposis and progression to dysplasia in a mouse model","volume":"9","author":"Hardiman","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0015","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.bpg.2011.08.002","article-title":"Chemoprevention in familial adenomatous polyposis","volume":"25","author":"Kim","year":"2011","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0020","first-page":"5713","article-title":"Dietary modulation of carcinoma development in a mouse model for human familial adenomatous polyposis","volume":"58","author":"Yang","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0025","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3109\/00365521.2010.487915","article-title":"ERbeta expression in normal, adenomatous and carcinomatous tissues of patients with familial adenomatous polyposis","volume":"45","author":"Barone","year":"2010","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0030","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/carcin\/bgp275","article-title":"Dietary-induced ERbeta upregulation counteracts intestinal neoplasia development in intact male ApcMin\/+ mice","volume":"31","author":"Barone","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0035","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.3748\/wjg.v19.i34.5671","article-title":"Eviendep(R) reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis","volume":"19","author":"Calabrese","year":"2013","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0040","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.tox.2005.06.020","article-title":"Effects of silymarin flavonolignans and synthetic silybin derivatives on estrogen and aryl hydrocarbon receptor activation","volume":"215","author":"Pliskova","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0045","doi-asserted-by":"crossref","DOI":"10.2174\/1389450115666140804124808","article-title":"Safety of nanoparticles in medicine","author":"Wolfram","year":"2015","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0050","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc1566","article-title":"Cancer nanotechnology: opportunities and challenges","volume":"5","author":"Ferrari","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0055","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1021\/ar200077p","article-title":"Multistage nanovectors: from concept to novel imaging contrast agents and therapeutics","volume":"44","author":"Godin","year":"2011","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2015.08.010","article-title":"Multistage vector (MSV) therapeutics","author":"Wolfram","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0065","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1002\/adfm.201200869","article-title":"Discoidal porous silicon particles: fabrication and biodistribution in breast cancer bearing mice","volume":"22","author":"Godin","year":"2012","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0070","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1002\/cphc.200900914","article-title":"Tailored porous silicon microparticles: fabrication and properties","volume":"11","author":"Chiappini","year":"2010","journal-title":"ChemPhysChem"},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0075","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1002\/jbm.a.35017","article-title":"Degradation and biocompatibility of multistage nanovectors in physiological systems","volume":"102","author":"Martinez","year":"2014","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0080","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/smll.201201939","article-title":"Short and long term, in vitro and in vivo correlations of cellular and tissue responses to mesoporous silicon nanovectors","volume":"9","author":"Martinez","year":"2013","journal-title":"Small"},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0085","doi-asserted-by":"crossref","first-page":"8469","DOI":"10.1016\/j.biomaterials.2013.07.049","article-title":"Engineering multi-stage nanovectors for controlled degradation and tunable release kinetics","volume":"34","author":"Martinez","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0090","article-title":"Multistage nanovectors enhance the delivery of free and encapsulated drugs","author":"Martinez","year":"2014","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0095","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1158\/0008-5472.CAN-09-3931","article-title":"Sustained small interfering RNA delivery by mesoporous silicon particles","volume":"70","author":"Tanaka","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2014.04.057","article-title":"Bone marrow endothelium-targeted therapeutics for metastatic breast cancer","volume":"187","author":"Mai","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0105","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature13119","article-title":"XBP1 promotes triple-negative breast cancer by controlling the HIF1alpha pathway","volume":"508","author":"Chen","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0110","doi-asserted-by":"crossref","first-page":"8838","DOI":"10.1073\/pnas.1320769111","article-title":"Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling","volume":"111","author":"Dave","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0115","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/smll.201201510","article-title":"Multistage vectored siRNA targeting ataxia-telangiectasia mutated for breast cancer therapy","volume":"9","author":"Xu","year":"2013","journal-title":"Small"},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0120","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1158\/1078-0432.CCR-12-2764","article-title":"Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery","volume":"19","author":"Shen","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0125","doi-asserted-by":"crossref","first-page":"9867","DOI":"10.1021\/nn4035316","article-title":"High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics","volume":"7","author":"Shen","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0130","first-page":"52075","article-title":"Porous silicon microparticles for delivery of siRNA therapeutics","volume":"15","author":"Shen","year":"2015","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0135","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.biomaterials.2013.09.033","article-title":"Polycation-functionalized nanoporous silicon particles for gene silencing on breast cancer cells","volume":"35","author":"Zhang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0140","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.canlet.2012.07.027","article-title":"Multistage delivery of chemotherapeutic nanoparticles for breast cancer treatment","volume":"334","author":"Blanco","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0145","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.tibtech.2009.12.007","article-title":"Frontiers in cancer nanomedicine: directing mass transport through biological barriers","volume":"28","author":"Ferrari","year":"2010","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0150","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1349-7006.2009.01103.x","article-title":"Preclinical and clinical studies of anticancer agent-incorporating polymer micelles","volume":"100","author":"Matsumura","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0155","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.4155\/tde.14.69","article-title":"Polymeric nano-micelles: versatile platform for targeted delivery in cancer","volume":"5","author":"Mohamed","year":"2014","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0160","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.addr.2008.08.005","article-title":"Active targeting schemes for nanoparticle systems in cancer therapeutics","volume":"60","author":"Byrne","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0165","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1016\/j.biomaterials.2014.04.088","article-title":"Targeting the thyroid gland with thyroid stimulating hormone (TSH)-nanoliposomes","volume":"35","author":"Paolino","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0170","doi-asserted-by":"crossref","first-page":"9824","DOI":"10.1016\/j.biomaterials.2014.08.024","article-title":"The effect of multistage nanovector targeting of VEGFR2 positive tumor endothelia on cell adhesion and local payload accumulation","volume":"35","author":"Martinez","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0175","doi-asserted-by":"crossref","first-page":"H278","DOI":"10.1002\/adma.201101541","article-title":"E-selectin-targeted porous silicon particle for nanoparticle delivery to the bone marrow","volume":"23","author":"Mann","year":"2011","journal-title":"Adv. Mater."},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0180","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/BJ20121751","article-title":"The metalloproteases meprin alpha and meprin beta: unique enzymes in inflammation, neurodegeneration, cancer and fibrosis","volume":"450","author":"Broder","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0185","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jconrel.2007.04.014","article-title":"Beta-lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells","volume":"122","author":"Blanco","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0190","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.colsurfb.2013.10.009","article-title":"Shrinkage of pegylated and non-pegylated liposomes in serum","volume":"114C","author":"Wolfram","year":"2014","journal-title":"Colloids Surf. B. Biointerfaces"},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0195","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3109\/02652048.2013.879932","article-title":"Evaluation of anticancer activity of celastrol liposomes in prostate cancer cells","volume":"31","author":"Wolfram","year":"2014","journal-title":"J. Microencaps."},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0200","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0029-1242458","article-title":"Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors","volume":"22","author":"Haggar","year":"2009","journal-title":"Clin. Colon Rectal Surg."},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0205","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/cncr.22007","article-title":"Descriptive epidemiology of colorectal cancer in the United States, 1998\u20132001","volume":"107","author":"Jackson-Thompson","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0210","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1101\/gad.1593107","article-title":"The genetics of hereditary colon cancer","volume":"21","author":"Rustgi","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0215","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF02258397","article-title":"Overview of the epidemiology of colorectal cancer","volume":"40","author":"Wilmink","year":"1997","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0220","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jso.2930240119","article-title":"Sulindac for polyposis of the colon","volume":"24","author":"Waddell","year":"1983","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0225","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1136\/gut.38.5.707","article-title":"Sulindac increases the expression of APC mRNA in malignant colonic epithelial cells: an in vitro study","volume":"38","author":"Schnitzler","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0230","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1478-811X-11-73","article-title":"Sulindac activates NF-kappaB signaling in colon cancer cells","volume":"11","author":"Mladenova","year":"2013","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0235","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.amjmed.2009.04.018","article-title":"Side effects of phytoestrogens: a meta-analysis of randomized trials","volume":"122","author":"Tempfer","year":"2009","journal-title":"Am. J. Med."},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0240","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrd2614","article-title":"Nanoparticle therapeutics: an emerging treatment modality for cancer","volume":"7","author":"Davis","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0245","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.2217\/fon.13.146","article-title":"Liposomal chemotherapeutics","volume":"9","author":"Gentile","year":"2013","journal-title":"Future Oncol."},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0250","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1073\/pnas.1220281110","article-title":"Ligand-functionalized nanoparticles target endothelial cells in retinal capillaries after systemic application","volume":"110","author":"Pollinger","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0255","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s003940050052","article-title":"Intestinal absorption of lycopene from different matrices and interactions to other carotenoids, the lipid status, and the antioxidant capacity of human plasma","volume":"38","author":"Bohm","year":"1999","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.colsurfb.2015.10.005_bib0260","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nut.2012.05.002","article-title":"Lipid effects of a dietary supplement softgel capsule containing plant sterols\/stanols in primary hypercholesterolemia","volume":"29","author":"Maki","year":"2013","journal-title":"Nutrition"}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776515302368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776515302368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T00:11:48Z","timestamp":1589587908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776515302368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":52,"alternative-id":["S0927776515302368"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2015.10.005","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multistage vector delivery of sulindac and silymarin for prevention of colon cancer","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2015.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}